top of page
Medical Consultation

Clinical Research

We offer hope to those with retinal diseases by providing access to clinical trials that could potentially improve their condition and advance the treatment outcomes for future patients

(925) 265-4146

Current Clinical Trials

Diabetic Macular Edema (DME)
Geographic Atrophy (GA)
Intermediate Age-Related Macular Degeneration (iAMD)
Macular Telangiectasia (MacTel)
Wet Age-Related Macular Degeneration (wAMD)

Diabetic Macular Edema (DME)

STAMP

Investigator-Led

Steroid vs. Anti-VEGF for Diabetic Macular Edema Prior to Phacoemulsification

Geographic Atrophy (GA)

ARCHER II

Annexon

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients with Geographic Atrophy (GA)

Learn More

ReNEW

StealthBio Therapeutics

ReNEW: A Phase 3, Double-Masked, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects Who Have Dry Age-Related Macular Degeneration (Dry AMD)

Learn More

MAGNIFY

Cognition Therapeutics

A Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants with Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Learn More

GARLAND

Apellis Pharmaceuticals, Inc

A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World
Safety, Tolerability and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients with
Geographic Atrophy Secondary to Age-Related Macular Degeneration

Learn More

PARASOL

Janssen

A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Learn More

Intermediate Age-Related Macular Degeneration (iAMD)

HONU

Genentech

A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

Learn More

Macular Telangiectasia (MacTel)

NHOR

The Lowy Medical Research Institute

The Natural History Observation Registry (NHOR) is a world-wide registry of individuals with Macular Telangiectasia type 2, and their family members.

Learn More

Wet Age-Related Macular Degeneration (wAMD)

SOL

Ocular Therapeutix

A Phase 3, Multicenter, Double-Masked, Randomized, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)

Learn More

ASCENT

AbbVie

A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD

Learn More

PROTOCOL AO

DRCR

This study compares Home OCT-Guided Treatment versus Treat and Extend for the management of neovascular (wet) AMD.

Learn More

CONQUER

Affamed Therapeutics

A Prospective, Multi-Center, Open-label, Sequential, Multiple Ascending-Dose and High Concentration Cohorts Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AM712 Following Intravitreal Administration in Patients With Neovascular Age-related Macular Degeneration.

Learn More
DME
GA
iAMD
MacTel
wAMD

Closed Trials

AERIE

ALTISSIMO

AVANTE

BHAM

ALEXION

ARCHWAY

AVENUE

BI GA

ALLUVIUM

ASPIRE

BARDENAS

BOULEVARD

DERBY

GALE

NTMT

PREGONDA

DRCR

GALLEGO

OMASPECT

RAVEN

FOCUS

KINGFISHER

PANDA

RHINE

SAPPHIRE

Button

STAMP

VAPOR

Button

SPECTRI

Button

SUSHI

Button

STAIRWAY

Button
bottom of page